Cargando…
Glucocorticoids regulate lipid mediator networks by reciprocal modulation of 15-lipoxygenase isoforms affecting inflammation resolution
Glucocorticoids (GC) are potent anti-inflammatory agents, broadly used to treat acute and chronic inflammatory diseases, e.g., critically ill COVID-19 patients or patients with chronic inflammatory bowel diseases. GC not only limit inflammation but also promote its resolution although the underlying...
Autores principales: | Rao, Zhigang, Brunner, Elena, Giszas, Benjamin, Iyer-Bierhoff, Aishwarya, Gerstmeier, Jana, Börner, Friedemann, Jordan, Paul M., Pace, Simona, Meyer, Katharina P. L., Hofstetter, Robert K., Merk, Daniel, Paulenz, Christian, Heinzel, Thorsten, Grunert, Philip C., Stallmach, Andreas, Serhan, Charles N., Werner, Markus, Werz, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469032/ https://www.ncbi.nlm.nih.gov/pubmed/37603745 http://dx.doi.org/10.1073/pnas.2302070120 |
Ejemplares similares
-
Allosteric Activation of 15‐Lipoxygenase‐1 by Boswellic Acid Induces the Lipid Mediator Class Switch to Promote Resolution of Inflammation
por: Börner, Friedemann, et al.
Publicado: (2022) -
Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids
por: Gheorghe, Karina Roxana, et al.
Publicado: (2009) -
Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase
por: Garscha, Ulrike, et al.
Publicado: (2017) -
Discovery of the first dual inhibitor of the 5-lipoxygenase-activating protein and soluble epoxide hydrolase using pharmacophore-based virtual screening
por: Temml, Veronika, et al.
Publicado: (2017) -
Stop-and-Go: Dynamics of Nucleolar Transcription During the Cell Cycle
por: Iyer-Bierhoff, Aishwarya, et al.
Publicado: (2019)